HVB MINI FUTURE BULL - ROCHE GS Share Price

Certificat

DE000HC4XS03

Market Closed - BOERSE MUENCHEN 20:45:55 31/05/2024 BST
2.53 EUR +18.78% Intraday chart for HVB MINI FUTURE BULL - ROCHE GS
1 month+76.92%
3 months+23.41%
Date Price Change
31/05/24 2.53 +18.78%
30/05/24 2.13 -7.39%
29/05/24 2.3 +5.50%
28/05/24 2.18 -5.63%
27/05/24 2.31 -1.70%

Real-time BOERSE MUENCHEN

Last update May 31, 2024 at 08:45 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer UniCredit UniCredit
WKN HC4XS0
ISINDE000HC4XS03
Date issued 13/03/2023
Strike 207.8 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 5.53
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 9.15
Lowest since issue 0.74
Spread 0.08
Spread %3.02%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
231 CHF
Average target price
277.5 CHF
Spread / Average Target
+20.14%
Consensus